MARKET

PSNL

PSNL

Personalis
NASDAQ
6.04
+0.26
+4.50%
After Hours: 6.04 0 0.00% 16:01 05/12 EDT
OPEN
5.79
PREV CLOSE
5.78
HIGH
6.21
LOW
5.70
VOLUME
1.48M
TURNOVER
--
52 WEEK HIGH
11.50
52 WEEK LOW
3.840
MARKET CAP
632.52M
P/E (TTM)
-5.9396
1D
5D
1M
3M
1Y
5Y
1D
Personalis Price Target Cut to $9.00/Share From $10.00 by Morgan Stanley
Dow Jones · 5h ago
Personalis Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 5h ago
Morgan Stanley Maintains Equal-Weight on Personalis, Lowers Price Target to $9
Benzinga · 5h ago
Personalis price target lowered to $9 from $10 at Morgan Stanley
TipRanks · 8h ago
Analysts Are Bullish on These Healthcare Stocks: CVRx (CVRX), Personalis (PSNL)
TipRanks · 10h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX), Personalis (PSNL) and Alpha Tau Medical Ltd (DRTS)
TipRanks · 10h ago
Personalis price target lowered to $11 from $13 at BTIG
TipRanks · 1d ago
Personalis Price Target Cut to $11.00/Share From $13.00 by BTIG
Dow Jones · 1d ago
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.